Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells
- 1 February 2006
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 65 (2) , 157-163
- https://doi.org/10.1136/ard.2005.035378
Abstract
Background: Rheumatoid arthritis (RA) is associated with increased morbidity and mortality attributable to accelerated atherosclerosis and cardiovascular events. Objective: To determine the role played by endothelial progenitor cells (EPC) in the defence system against arteriosclerosis. Methods: The number and function of EPC in 13 young patients with RA with low disease activity (DAS28 3.5 (0.3)) and 13 healthy control subjects was studied. Endothelial function was investigated by agonist-induced, endothelium dependent vasodilatation measured by the forearm blood flow technique. Migratory activity and adhesion of EPC to tumour necrosis factor α (TNFα) activated mature endothelial cells and components of the extracellular matrix were tested in vitro. Putative precursor populations (CD34+, CD34+/CD133+, and CD34+/KDR+ haematopoietic stem cells) were measured by flow cytometric analysis. Results: Acetylcholine-induced, endothelium dependent vasodilatation was reduced by about 50% in patients with RA, indicating endothelial dysfunction, whereas endothelium-independent vasodilatation in response to glyceryl trinitrate was at control level. Significantly reduced numbers of EPC were found in the patients compared with controls. Migratory activity of EPC was decreased in patients with RA. Adhesion to mature endothelial cells after activation with TNFα was enhanced only in controls. The adhesion to matrix proteins and the number of putative precursor cell lineages was comparable in both groups. Conclusion: Endothelial dysfunction in patients with RA with low grade inflammation is associated with a reduced number and partial dysfunction of EPC. Further studies are needed to explore whether interventions that potentially ameliorate the number and function of EPC also improve endothelial function in these patients.Keywords
This publication has 23 references indexed in Scilit:
- C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cellsBiochemical and Biophysical Research Communications, 2004
- Defective vasculogenesis in systemic sclerosisThe Lancet, 2004
- Endothelial precursor cells in the synovial tissue of patients with rheumatoid arthritis and osteoarthritisArthritis & Rheumatism, 2004
- C-Reactive Protein Attenuates Endothelial Progenitor Cell Survival, Differentiation, and FunctionCirculation, 2004
- Mesenchymal Stem Cells Can Be Differentiated Into Endothelial Cells In VitroThe International Journal of Cell Cloning, 2004
- Explaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid ArthritisCirculation, 2003
- Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular RiskNew England Journal of Medicine, 2003
- Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery DiseaseCirculation Research, 2001
- CD34−Blood‐Derived Human Endothelial Cell ProgenitorsThe International Journal of Cell Cloning, 2001
- Suppression of Inflammation in Primary Systemic Vasculitis Restores Vascular Endothelial Function: Lessons for Atherosclerotic Disease?Circulation, 2000